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Abstract
Myeloid cells are a feature of most tissues. Here we show that during development, retinal
myeloid cells (RMCs) produce Wnt ligands to regulate blood vessel branching. In the mouse
retina, where angiogenesis occurs postnatally1, somatic deletion in RMCs of the Wnt ligand
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transporter Wntless2,3 results in increased angiogenesis in the deeper layers. We also show that
mutation of Wnt5a and Wnt11 results in increased angiogenesis and that these ligands elicit RMC
responses via a non-canonical Wnt pathway. Using cultured myeloid-like cells and RMC somatic
deletion of Flt1, we show that an effector of Wnt-dependent suppression of angiogenesis by
RMCs is Flt1, a naturally occurring inhibitor of vascular endothelial growth factor (VEGF)4-6.
These findings indicate that resident myeloid cells can use a non-canonical, Wnt-Flt1 pathway to
suppress angiogenic branching.
Myeloid cells have a wide array of biological activities that include immune activation,
arteriogenesis7, and regulation of salt balance and blood pressure8. Myeloid cells also
regulate vascularity. Tumor associated macrophages influence the growth of blood vessels9
in part because they are a source of VEGFA10. Myeloid cells also promote angiogenic
branching11 and anastamosis12. Depending on the context, myeloid cells can be either anti-
angiogenic13 or pro-angiogenic14. Here we show that RMCs suppress retinal angiogenesis
via a Wnt-Flt1 pathway (Fig S1).
Retinal angiogenesis begins on the day of birth in the mouse with the formation of a
superficial vascular plexus (Fig. 1a) that lies within the ganglion cell layer15. After
formation of this superficial plexus by P7 (post-partum day 7), angiogenic sprouts descend
vertically through the retinal layers from P8 to P14 (Fig. 1a). At the outer edge of the inner
nuclear layer (INL) the vertical angiogenic sprouts turn and simultaneously branch to form a
deep vascular plexus (Fig. 1a). Using antibodies to the vascular endothelial cell (VEC)
marker endomucin and to the GFP of the cfms-eGFP transgene that marks RMCs, we show
that myeloid cells have a unique spatial relationship with angiogenic tip cells. At the point of
turning and branching in the outer INL, myeloid cells and angiogenic sprouts are in close
contact (Fig. S2a). This was confirmed by labeling with isolectin and F4/80 (Fig. S2b). We
then took advantage of high-intensity isolectin labeling of VECS and RMCs and performed
a 3D reconstruction with false coloring to illustrate the overall topology of the angiogenic
tip cell-RMC interaction (Fig. 1b). This showed close contact between the two cell types
throughout turn-and-branch angiogenesis in the deep retinal layer. Furthermore, after
turning, angiogenic tip cells extend within the plane of the deep retinal layer and remain
RMC-associated (Fig. 1c). In further defining RMCs, we showed that CD204 was unique to
RMCs with amoeboid morphology in the superficial retinal layer (Fig. S2c, d). By contrast,
deep retinal layer RMCs with extended morphology were CD204-negative (Fig. S2c, e).
Both layers of RMCs expressed Iba116 but at different levels (Fig. S2c-e). This information
allowed us to flow sort distinct populations of superficial (CD11b+, F4/80+, CD204+) and
deep layer (CD11b+, F4/80+, CD204-) RMCs (Fig. 1d, e).
Based on prior work showing vascular regulation by myeloid Wnt ligands17 we
hypothesized that RMCs might use Wnt ligands to regulate retinal angiogenesis. First, we
examined the expression of Wnt ligands and receptors in superficial and deep RMCs
isolated by flow-sorting. RT-PCR analysis of the deep RMC population revealed expression
of Wnt5a, Wnt6 and Wnt11, Fzd7 and Fzd8 as well as the co-receptor Lrp5 (Fig. 1f). With
the exception of Wnt5b, which was inconsistent, all other Wnt ligands were not detected in
deep RMCs. Superficial RMCs expressed similar Wnts and Fzds (Fig. 1f) but also expressed
Wnts 2b, 3 and 3a (data not shown).
The challenge of genetic analysis when RMCs express many Wnt ligands was addressed by
the generation of a loxP-flanked conditional allele for the essential Wnt ligand transporter
Wls/GPR1772,3. Both superficial and deep RMCs expressed Wls (Fig. 1f). Wls was deleted
using the myeloid cre driver cfms-icre18 which we confirmed was functional in RMCs (Fig.
S3a-c). To analyze retinal vasculature, we imaged superficial and deep retinal vessels at P18
(Fig. 2a). Quantification of vessel branch points showed that cfms-icre alone had no effect
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(Fig. 3b). Furthermore, compared with control Wls+/fl mice, Wls+/fl; cfms-icre animals had a
normal superficial vascular plexus (Fig. 2a, green, Fig. 2c). By contrast, the deep vascular
layer (Fig. 2a, red, Fig. 2c) showed an overgrowth. Interestingly, no further enhancement of
vascular overgrowth was apparent when the myeloid Wls deletion was homozygous as in
Wls−/fl; cfms-icre mice (data not shown). Since myeloid cells are positioned below
descending vessels at P10, we assessed vessel branching at the base of these sprouts. Wls+/fl;
cfms-icre mice exhibited reduced simple turning (no branches) and single branching, but
significantly more multi-branch events (Fig. 2d). As a weighted mean, the branch index was
2.0 in control and 3.2 in the mutant (p<0.0001).
The higher vascular density of the deep layer in Wls+/fl; cfms-icre mice could reflect
enhanced angiogenesis or defective remodeling. To assess this, we counted deep layer
branch points in control (Wlsfl/+) and experimental (Wlsfl/+; cfms-icre) mice over a time-
course from P6 to P18 (Fig. 2e). Between P14 and P18 when remodeling predominates (Fig.
2e, red zone) control and mutant graph slopes were nearly identical. By contrast, between P6
and P14 when vessel growth predominates (Fig. 2e, green zone), the slope of the graph is
greater in the mutant. There was no difference between control and mutant animals in the
number of vertical sprouts connecting superficial and deep layers (Fig. S3d). Combined, the
data in Fig. 2 are consistent with a model in which myeloid Wnt ligands suppress branch
formation as angiogenic sprouts make contact with deep layer RMCs (Fig. 1b, c). These data
were corroborated by the vascular overgrowth phenotype of Wnt5a19 and Wnt1120
heterozygotes (Figs. S3e, f and S4).
Wnt5a and Wnt11 are most often associated with non-canonical Wnt signaling21. We thus
investigated the possibility that Wnt-dependent suppression of deep retinal angiogenesis was
a non-canonical response. Wnt3a, but not Wnt5a, elicited a canonical response in
SuperTopflash (STF) reporter cells (Fig. S5a). Some non-canonical Wnt pathways activate a
Ca2+ flux21. To determine whether myeloid Wnts elicited a Ca2+ flux, we added Wnt5a to
myeloid-like RAW264.7 cells and measured Ca2+-dependent Fura-2 dye emission.
Recombinant Wnt5a increased intracellular Ca2+ compared to untreated controls (Fig. 3a,
S5b, c). Furthermore, to assess the requirement for Wls in Wnt ligand secretion, we exposed
RAW264.7 cells to medium from Wlsfl/fl MEFs transfected with Wnt5a or Wnt5a and cre
recombinase plasmids. RAW264.7 cells had increased Ca2+ flux in response to Wnt5a-
transfected MEF medium relative to Wnt5a- and cre-transfected medium (Fig. 3b). This
validates the role of Wls in secretion of Wnt5a. Combined, these data show that one myeloid
Wnt, Wnt5a, does not stimulate a canonical Wnt response but can elicit a Ca2+ flux
characteristic of some non-canonical Wnt responses.
In recent work, it has been shown that Wnt5a loss-of-function can rescue the defects
associated with deletion of the canonical Wnt pathway co-receptors Lrp5/622. This finding
has suggested that Lrp5/6 deletion actually represents a non-canonical pathway gain-of-
function and that in deleting the non-canonical ligand Wnt5a, there is a re-balancing of
pathway activity. This hypothesis is supported by biochemical analysis showing that Wnt5a
can bind Lrp6, but does not elicit the phosphorylation required for canonical signaling22.
Canonical, non-canonical reciprocal pathway inhibition has also been demonstrated23. These
findings argue that a deletion of Lrp5/6 can define whether a Wnt signaling pathway is
canonical or non-canonical. If canonical, an Lrp5/6 deletion will give the same phenotype as
ligand deletion. By contrast, if the signaling pathway is non-canonical, the consequence of
Lrp5/6 deletion would be opposite to that of ligand mutation. Thus, to determine whether the
RMC response was canonical or non-canonical, we generated a cfms-icre somatic mutant of
the Lrp5 coreceptor that is expressed in RMCs (Fig. 1f). Since the result was significantly
diminished deep vascular layer density in somatic homozygotes (Fig 3c-f), a response
opposite to ligand deletion, this provides in vivo evidence that the Wnt response is non-
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canonical. Even though the superficial vascular layer was slightly deficient in somatic
homozygotes (Fig. 3e) this was not the reason reduced density in the deep vascular layer as
the descending sprout number was unchanged (Fig. 3f).
The VEGF receptor Flt1 (also known as VEGFR1) can suppress angiogenesis because it has
limited signaling capacity, a higher affinity for VEGF than Flk1 (VEGFR2) and can
sequester VEGF5,6. Alternative splicing produces both membrane tethered (mFlt1) and
soluble (sFlt1) forms5. Flt1 is known to contribute to corneal avascularity4 as well as the
selection of angiogenic tip cells when expressed regionally in an existing vessel24. Flt1 is
also known to be expressed in some myeloid populations6. Since angiogenesis in the deep
retinal layers is VEGF-dependent25, Flt1 was a good candidate to mediate Wnt-dependent
angiogenic suppression by deep RMCs.
We thus determined whether Flt1 was expressed in P12 RMCs by performing end-point RT-
PCR on flow-sorted cells using primers that detected both transcripts. This showed that deep
RMCs expressed Flt1 (Fig. 4a). By contrast, superficial RMCs did not (Fig. 4a). We also
showed that Iba1-labeled RMCs positioned at the outer edge of the INL labelled with anti
Flt1 antibodies (Fig. 4b). We then generated an RMC Flt1 loss-of-function using cfms-icre
and the Flt1fl conditional allele26. Quantification of retinal vascular branch points in Flt1+/fl;
cfms-icre mice at P18 showed that the superficial layer was unaffected but that the deep
layer showed an increase in density (Fig. 4c, d). As with Wls somatic mutants, conditional
homozygosity for Flt1 (Flt1fl/fl; cfms-icre) did not give a further significant increase in
vascular density (data not shown). Furthermore, the number of deep RMCs was unchanged
(Fig. S2g).
These data showed that conditional deletion of Flt1 produced an enhancement of
angiogenesis similar to that observed with conditional deletion of Wls. One implication was
that Wls and Flt1 might function in the same angiogenesis suppression pathway. To test the
possibility that Flt1 might be regulated by Wnt ligands, we used myeloid-like RAW264.7
cells that, like RMCs, express Fzd7 and Fzd8 (Fig. 4e). When stimulated with the
“canonical” ligand Wnt3a, RAW264.7 did not change the level of Flt1 transcript according
to QPCR (Fig. 4f). However, stimulation with Wnt5a produced a 3-fold increase in the level
of both Flt1 isoform transcripts (Fig. 4f). Furthermore, an ELISA showed that there was an
increased level of sFlt1 in conditioned media from Wnt5a stimulated RAW264.7 cells (Fig.
4g). Wnt3a stimulation again had no effect (Fig. 4g).
As a stringent test of the possibility that Wnt ligands stimulated expression of Flt1 in deep
RMCs, we flow sorted the CD11b+, F4/80+, CD204-population from both control (Wls+/fl)
and experimental (Wls+/fl; cfms-icre) mice at P12 and performed QPCR for Flt1 transcripts.
We were never able to amplify the mFlt1 transcript but showed that there was a 90%
reduction in transcript level for sFlt1 (Fig. 4h). This was consistent with the maximal
phenotype observed in the heterozygous conditional Wls mutants. Though a heterozygous
phenotype is not unusual, it is perhaps surprising that conditional homozygosity gave no
further significant change. This kind of response might be explained by a low signaling
sensitivity threshold for the Wnt-Flt1 pathway.
The data we describe reveal that RMCs can directly modulate angiogenic responses by
producing the VEGF inhibitory receptor Flt1. Unexpectedly, we also show that the
production of Flt1 depends on myeloid non-canonical Wnt ligands. In this setting, myeloid
Wnt ligands might function in autocrine stimulation as has been documented for cultured
macrophages27 or might operate via a more complex pathway involving another cell type as
an intermediate. The Wnt-Flt1 response represents a new pathway for the regulation of
VEGF-stimulated angiogenesis. The targeting of appropriate Fzd receptors or other Wnt-
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Flt1 pathway components may offer new opportunities to modulate the production of Flt1
and thus, the VEGF-stimulated angiogenic response. Since macrophage-related cells are
ubiquitous and highly mobile, it is possible that the Wnt-Flt1 pathway will be a general
means to suppress VEGF locally and thus to tamp-down vascular responses. In future
studies it will be interesting to determine, for example, if this pathway is active in the
suppression of wound angiogenesis by macrophages13 or is inactivated in macrophage-
dependent tumor angiogenesis28.
Additionally, our observations are consistent with a string of recent papers expanding the
role of myeloid cells beyond their well-documented functions in innate immunity7,8,17,29.
These findings build on an idea articulated by Ilya Metchnikoff nearly a century ago. He
suggested that phagocytes originally evolved to regulate developmental processes, and that
their immune functions were a later evolutionary adaptation. He proposed that macrophages
were the “policemen” of multi-cellular organisms, and that they, in his words, could
establish “harmony from chaos.”30 Here we show, in the setting of the retina, that myeloid
cells do just that by fine-tuning vascular density and directing vascular traffic.
Methods Summary
We prepared and stained retinas as previously reported1. To isolate RMCs, we digested
retinas, pre-enriched with CD11b beads, and sorted for surface makers with the FACSAria
II. To obtain conditioned medium from MEFs, we performed transient transfections with
Wnt5a, Thy1.1 and cre plasmids, sorted Thy1.1-positive MEFS, and re-plated transfected
cells. We performed calcium imaging on RAW264.7 cells loaded in Ringer’s solution with 5
μM Fura-2 AM and imaged at 510 nm at 1 Hz after excitation at 340 nm and 380 nm. All
animal experiments were performed in accordance with IACUC-approved guidelines and
regulations.
Methods
Quantification of retinal vasculature and isolation of RMCs
Retinas were prepared and imaged as reported1 except that Alexa Fluor 488 isolectin GS-
IB4 (Invitrogen) was used to label retinal vessels and RMCs. Other Abs included anti-
endomucin (Santa Cruz, V.7C7), anti-GFP (Abcam), anti-Iba1 (Wako), anti-CD204 (AbD
Serotec), and anti-Flt1 (R&D). For quantification, we used 200× magnification images
located at the retinal periphery between artery and vein. For each genotype, at least 3 fields
were analyzed from at least 4 animals from a minimum of 2 litters. Control and
experimental animals were littermates. This minimized the effect of strain background in
producing variation in vascular density31-34. For flow sorting, retinas were digested and
sorted as reported16 except that 0.5 mg/mL DNase II (Sigma Aldrich) was used.
Furthermore, myeloid cells were pre-enriched using CD11b beads (Miltenyi Biotech). Cells
were then incubated with anti-CD16/32 (clone 24.G2) for 30 minutes and labelled with
mAbs to PE-Cy7 conjugated anti-CD11b (clone M1/70), APC-Cy7 or PerCP-Cy5.5
conjugated anti-F4/80 (clone BM8), Alexa-647 conjugated anti-CD204 (clone 2F8), and 7-
AAD. Cells were sorted with FACSAria II running DiVa software.
RNA Isolation and RT-PCR
RNA was isolated using RNeasy (Qiagen). QPCR was performed with QuantiTect SYBR
green (Qiagen). Primers are listed in Supplementary Table 1.
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MEFs were isolated as described35 from Wlsfllfl mice36 and transfected with combinations of
2.5 μg Wnt5a, Thy1.1 and cre plasmids using TransIT-2020 (Mirus). MEFs were sorted
using magnetic beads for Thy1.1, replated and supernatant was collected after 24 hours.
RAW264.7 cells (ATCC) were cultured in DMEM (10% FBS) and treated with recombinant
Wnt3a (10 ng/mL, R&D) or Wnt5a (500 ng/mL, R&D). ELISA was performed using the
sVEGFR1 Quantikine kit (R&D). For calcium imaging, RAW264.7 cells were loaded in
Riger’s solution with 5 μM Fura-2 AM and imaged at 510 nm at 1 Hz after excitation at 340
nm and 380 nm. Data was acquired using EasyRatioPro. Ca2+ traces are 50-cell averages
from 2 experiments.
Statistics
All statistical tests used are stated in the figure legends. In analyzing QPCR data, the p
values refer to a comparison of the ΔΔcT values.
Animals
Breeding and genotyping of Wlsfl (ref 36), cfms-icre (ref 18), Z/EG (ref 37), Wnt5a+/− (ref
19), Wnt11+/− (ref 20) and Fltfl (ref 26) was performed as previously described. Lrp5fl will
be described in detail in a forthcoming publication. The allele is a conventional design
where exon 2 of the Lrp5 gene is flanked by LoxP sites. It has been confirmed that deletion
between the LoxP sites produces a loss-of-function. All animal experimentation was carried
out using protocols approved by the Institutional Animal Care and Use Committee.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. RMCs interact with VECs and express Wnt components
(a) Schematic of retina at postnatal days (P) 2, 6, 10, and 18. RMCs interacting with
descending vertical sprouts are labeled with red arrowheads. Adapted from Ref 1. (b)
Isolectin-labeled 3D reconstruction of vertical angiogenic sprouts (green) and RMCs (false-
color red). (c) As in (b) but a 2D image in the deep vascular layer. 5 μm scale bars. (d, e)
Flow-sorting of deep layer RMCs based on surface markers. (f) PCR for Wnt pathway
components on flow-sorted RMCs. Red arrowheads indicate expected sizes.
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Figure 2. RMC Wls is required for suppression of deep angiogenic branching
(a) Isolectin labeling of superficial and deep retinal vasculature in Wls+/fl and Wls+/fl; cfms-
icre mice. 50 μm scale bars. (b, c) P18 vessel branch points in labeled genotypes. n=4 (b),
n=8 (c). (d) Branches emanating from the base of vertical sprouts in the P10 deep vascular
layer. n=8. (b-d) Used Student’s T-test (two-tailed). (e) Time-course of deep layer branches
in indicated genotypes. Shading shows when angiogenesis (green) and remodeling (red)
predominate. One Way ANOVA revealed p=0.0021. n=4 for each point. Errors are SEM.
NS – Not significant.
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Figure 3. Angiogenic suppression by RMCs is a non-canonical Wnt response
(a, b) Intracellular Ca2+ in RAW264.7 cells treated with Wnt5a (a) or supernatant from
Wlsfl/fl MEFs expressing Wnt5a or Wnt5a and cre (b). One Way ANOVA showed p<0.0001
for both. (c, d) Isolectin labeling of superficial and deep retinal vasculature in Lrp5+/fl (c)
and Lrpfl/fl; cfms-icre (d) mice. 50 μm scale bars. (e) P18 vessel branch points in labeled
genotypes. (f) Vertical vessels connecting to the deep layer in labeled genotypes. (e, f) Used
One Way ANOVA with Tukey’s post-hoc. n≥8 per genotype. Errors are SEM. NS – not
significant.
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Figure 4. Flt1 expression in myeloid cells is regulated by a Wnt pathway
(a) PCR for Flt1 transcript in flow-sorted RMCs. (b) P14 retinal sections labeled for Flt1 and
Iba1. 25 μm scale bars. (c) P18 vessel branch points in the superficial and deep vasculature
in Flt1+/fl and Flt1+/fl; cfms-icre mice (n=7, Student’s T-test). n=7. (d) Isolectin labeling of
the retinal vasculature in labeled genotypes. 50 μm scale bars. (e) PCR for indicated
transcripts in E11.5 whole embryo (con) and RAW264.7 cells. (f, g) QPCR (f) for sFlt1 and
mFlt1 in Wnt-treated RAW264.7 cells and ELISA (g) for sFlt1 on medium from Wnt-
treated RAW264.7 cells (n=4, One Way ANOVA). (h) QPCR for sFlt1 in flow-sorted deep
RMCs from Wls+/fl and Wls+/fl; cfms-icre mice (n=4, Student’s T-test). Errors are SEM. NS
– Not significant.
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